| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/03/2003 | WO2003000934A1 Bion1 is a novel ion channel |
| 01/03/2003 | WO2003000930A2 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000918A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 01/03/2003 | WO2003000916A2 Telomerase expression repressor proteins and methods of using the same |
| 01/03/2003 | WO2003000906A2 Plant disease resistance genes |
| 01/03/2003 | WO2003000905A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000904A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000902A1 Aphidicolin biosynthase cluster |
| 01/03/2003 | WO2003000900A1 White spot syndrome virus vaccine |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000898A1 Plant genes involved in defense against pathogens |
| 01/03/2003 | WO2003000897A2 Identification and characterization of phosphate transporter genes |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000895A1 Yeast transformation vector system comprising multicopy paromomycin-resistance gene |
| 01/03/2003 | WO2003000894A1 Polynucleotide vaccine |
| 01/03/2003 | WO2003000893A2 Nucleic acids encoding g protein-coupled receptors |
| 01/03/2003 | WO2003000891A2 Protein-protein interactions in the inner ear |
| 01/03/2003 | WO2003000890A1 Genetic vasculopathy |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000888A2 Method for separating bacterial cells and cell components |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000865A2 Human secreted proteins |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000863A2 Defensin polynucleotides and methods of use |
| 01/03/2003 | WO2003000862A2 Homeotic genes and proteins, and uses thereof |
| 01/03/2003 | WO2003000861A2 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000855A2 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000847A2 Membrane associated progesterone receptor |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000843A2 P53 binding protein-related protein in cardiomyopathy |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000735A2 Nucleic acids encoding olfactory receptors |
| 01/03/2003 | WO2003000734A2 Ion channel modulators |
| 01/03/2003 | WO2003000733A2 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
| 01/03/2003 | WO2003000732A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 01/03/2003 | WO2003000731A1 Stereostructural motif and three-dimensional structural coordinate of peptide and utilization thereof |
| 01/03/2003 | WO2003000730A1 Compounds that modulate estrogen actions |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000728A2 Testis protein, zsig86 |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000726A1 Crystal structure of the apc10/doc1 subunit of the human anaphase-promoting complex |
| 01/03/2003 | WO2003000725A2 Regulation of human lipoate-protein ligase b-like enzyme |
| 01/03/2003 | WO2003000724A2 Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders |
| 01/03/2003 | WO2003000723A1 Transport proteins for nitrogenous heterocycles and nucleic acids encoding them |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000719A2 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | WO2003000718A2 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000296A2 Treatment and diagnostic of b cell chronic lymphocytic leukaemia |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2003000280A2 Abin-mediated hepatitis protection |
| 01/03/2003 | WO2003000279A1 GEMININ AND orc3N INHIBIT REPLICATION OF HERPESVIRUSES, PAPILLOMAVIRUSES, AND POLYOMAVIRUSES |
| 01/03/2003 | WO2003000277A2 Antimicrobial peptides |
| 01/03/2003 | WO2003000193A2 Covalent coupling of botulinum toxin with polyethylene glycol |
| 01/03/2003 | WO2003000179A2 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | WO2003000111A2 Human ugrp (uteroglobin-related protein) 1 promoter and its use |
| 01/03/2003 | WO2003000046A1 Cyt28 serpentine receptor disruptions, compositions and methods relating thereto |
| 01/03/2003 | WO2003000038A2 Compositions and methods for modulating plant development |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2002090595A9 Methods for modulating an immune response by modulating krc activity |
| 01/03/2003 | WO2002077155A3 Keratinocyte growth factor-2 |
| 01/03/2003 | WO2002074973A8 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002066056A3 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 01/03/2003 | WO2002065089A3 Catabolite repression control (crc) gene and pseudomonas virulence |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002057467A3 Use of umbravirus in protection against post-transcriptional gene silencing |
| 01/03/2003 | WO2002055676A3 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 01/03/2003 | WO2002048185A3 Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative |
| 01/03/2003 | WO2002046430A3 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 01/03/2003 | WO2002045755A3 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002036628A3 New multimeric interferon beta polypeptides |
| 01/03/2003 | WO2002031149A3 Polyvalent cation-sensing receptor proteins in aquatic species |
| 01/03/2003 | WO2002030966A3 Alzheimer's disease-associated proteins |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020612A3 Human vomeronasal receptor-3 |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012518A3 Floral induction gene |
| 01/03/2003 | WO2002012330A3 Human secreted protein, zzp1 |
| 01/03/2003 | WO2002012329A3 Compositions and methods for the therapy and diagnosis of head and neck cancer |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002010386A3 Human vomeronasal receptor |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002006468A3 METHYL CpG BINDING DOMAIN NUCLEIC ACIDS FROM MAIZE |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |